Investment Projects

• Liliao ® Bumetanide Injection

Spec: 1.0mg × 2ml Approval Document No.: GYZZ H45020960

Product Characteristics:

Liliao ® Bumetanide Injection which is originally invented by our company has got invention patent of the state. Liliao ? Bumetanide Injection is a new kind of diuretics, which is chosen as nat ional basic medical care insurance medicine by the Ministry of Health, with the characteristics of quick effect, fast metabolism, wide administration approaches, little t oxin and side effects. As a most effective diuretics, now it is widely used all over the world such as Europe and America . Our company's Bumetanide raw material medicine has passed qualification of American FDA and its quality is better than other same kind products home and abroad.

This medicine is mainly used in curing edema diseases, including congestive heart failure, hepatocirrhosis, renal diseases, hypertension, preventive acute renal failure , hyperpotassaemia, hypercalcermia, dilute hypoglycemia, syndrome of inappropriate ADH secretion (SIADH) and acute drug and poison toxicosis, etc.

This medicine is widely used and its market potential is great.

• Kaximeng ® Salcatonin Injection

Spec: 1ml: 50 Unit Approval Document No.: GYZZ H20010361

Product Characteristics:

Kaximeng ® Salcatonin Injection is a national basic medical care insurance medicine and it is a kind of calcitonin. Its activity is 10 to 40 times higher than human calcitonin and it can be used in regulating calcium metabolism, restraining the activity of bone-destroyed cell, preventing the lose of bone calcium, promoting the formation of bone cell, increasing bone amount, etc. And it can also directly act on nerve center to relax the pain of osteoporosis quickly and obviously, is a fine preparation in curing osteoporosis, etc. it has been already widely used home and abroad.

This medicine is mainly used in curing of senile osteoporosis, with itai-itai of osteolysis or osteopenia (Paget's disease), osteoporosis after menopause, tumor osteolysis caused by other secondary malignance in galactophore, lung, kidney, and hypercalcemia caused by careinomatous metastasis and their crises, etc.

As a medicine to supplement calcium and prevent calcium losses, its market prospect is very good among the elders. Its effects are obvious and it has a good investment and business value.

Qualifications

• Area requested for agency;

• Has stable terminal networks;

• Has experiences and foundation to engage in medicinal agent business;.

• Well know the pharmacology a nd medicinal efficacy of medicines under agency